2022
DOI: 10.34119/bjhrv5n3-066
|View full text |Cite
|
Sign up to set email alerts
|

O efeito do vírus SARS-CoV-2 na audição de pacientes adultos / The effect of the SARS-CoV-2 virus on hearing in adult patients

Abstract: Introdução: Embora o COVID-19 esteja relacionado as manifestações otorrinolaringológicas, como tosse, odinofagia, dispneia, anosmia e disgeusia, estudos apontam que o SARS-COV-2 pode afetar também o sistema auditivo. Metodologia: Trata-se de uma revisão integrativa, realizada através da análise de artigos obtidos nas bases de dados Scielo, Pubmed, Dimensions, ScienceDirect e Embase. Foram utilizados descritores relacionados a Disfunções Auditivas e COVID-19, sendo selecionados apenas artigos no idioma inglês e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…Studies reported that the SARS-CoV-2 virus has the capacity to invade the cell through the angiotensinconverting enzyme type 2 (ACE2) receptor, present in the inferior respiratory tract epithelium and in cells from the small intestine mucosa [Cespedes;Souza, 2020]. Vestibulocochlear disorders, in this context, may be due to auditory centres invasion through ACE2 receptors, such as the temporal lobe, or peripheral lesions caused by local hypoxia and immune-mediated mechanisms [Kozan et al, 2022]. SARS-CoV-2 neurotropic effects possibly lead to alterations in neural networks that convey balance and hearing, as well as patients may receive ototoxic medications during treatment [Karimi-Galougahi et al, 2021].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Studies reported that the SARS-CoV-2 virus has the capacity to invade the cell through the angiotensinconverting enzyme type 2 (ACE2) receptor, present in the inferior respiratory tract epithelium and in cells from the small intestine mucosa [Cespedes;Souza, 2020]. Vestibulocochlear disorders, in this context, may be due to auditory centres invasion through ACE2 receptors, such as the temporal lobe, or peripheral lesions caused by local hypoxia and immune-mediated mechanisms [Kozan et al, 2022]. SARS-CoV-2 neurotropic effects possibly lead to alterations in neural networks that convey balance and hearing, as well as patients may receive ototoxic medications during treatment [Karimi-Galougahi et al, 2021].…”
Section: Introductionmentioning
confidence: 99%
“…Many vestibular and auditory signs and symptoms, permanent or transitory, have been reported after CO-VID-19, such as hypoacusis, tinnitus, and vertigo [Almufarrij et al, 2020;Munro et al, 2020;Mustafa, 2020;Kozan et al, 2022]. After 2 years of pandemic, researchers around the world have been trying to grasp phenomena, diagnosis, treatment, and follow-up of acute and chronic sequelae post-COVID-19.…”
Section: Introductionmentioning
confidence: 99%